Skip to main content
Cardiovascular Diabetology logoLink to Cardiovascular Diabetology
. 2021 Sep 4;20:177. doi: 10.1186/s12933-021-01371-x

Correction to: Sodium–glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta‑analysis

Hang-Long Li 1,6, Gregory Y H Lip 2,3, Qi Feng 4, Yue Fei 5, Yi-Kei Tse 1, Mei-zhen Wu 1,6, Qing-wen Ren 1,6, Hung-Fat Tse 1,6, Bernard-M Y Cheung 5, Kai-Hang Yiu 1,6,
PMCID: PMC8418742  PMID: 34481507

Correction to: Cardiovasc Diabetol (2021) 20:100 10.1186/s12933-021-01293-8

Following publication of the original article [1], the authors noticed an error in the second author’s name.

The name of the second author, "Gregory Y. H. Lip", was incorrectly written as "Gregory-Y H Lip". This has been corrected with this erratum.

The original article [1] has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Li HL, Lip GYH, Feng Q, Fei Y, Tse YK, Wu M, Ren Q, Tse HF, Cheung BMY, Yiu KH. Sodium–glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis. Cardiovasc Diabetol. 2021;20:100. doi: 10.1186/s12933-021-01293-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cardiovascular Diabetology are provided here courtesy of BMC

RESOURCES